BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu X, Liu L, Wang Y, Cong J, Lin Z, Wang Y, Liu Q, Wang L, Yang B, Li T. lncRNA MIAT/HMGB1 Axis Is Involved in Cisplatin Resistance via Regulating IL6-Mediated Activation of the JAK2/STAT3 Pathway in Nasopharyngeal Carcinoma. Front Oncol 2021;11:651693. [PMID: 34094941 DOI: 10.3389/fonc.2021.651693] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Peña-flores JA, Bermúdez M, Ramos-payán R, Villegas-mercado CE, Soto-barreras U, Muela-campos D, Álvarez-ramírez A, Pérez-aguirre B, Larrinua-pacheco AD, López-camarillo C, López-gutiérrez JA, Garnica-palazuelos J, Estrada-macías ME, Cota-quintero JL, Barraza-gómez AA. Emerging role of lncRNAs in drug resistance mechanisms in head and neck squamous cell carcinoma. Front Oncol 2022;12:965628. [DOI: 10.3389/fonc.2022.965628] [Reference Citation Analysis]
2 Xiao J, He X. Involvement of Non-Coding RNAs in Chemo- and Radioresistance of Nasopharyngeal Carcinoma. Cancer Manag Res 2021;13:8781-94. [PMID: 34849030 DOI: 10.2147/CMAR.S336265] [Reference Citation Analysis]
3 Liguori G, Cerrone M, De Chiara A, Tafuto S, Tracey de Bellis M, Botti G, Di Bonito M, Cantile M. The Role of lncRNAs in Rare Tumors with a Focus on HOX Transcript Antisense RNA (HOTAIR). Int J Mol Sci 2021;22:10160. [PMID: 34576322 DOI: 10.3390/ijms221810160] [Reference Citation Analysis]
4 Danni X, Jiangzheng Z, Huamao S, Yinglian P, Changcheng Y, Yanda L. Chaperonin containing TCP1 subunit 3 (CCT3) promotes cisplatin resistance of lung adenocarcinoma cells through targeting the Janus kinase 2/signal transducers and activators of transcription 3 (JAK2/STAT3) pathway. Bioengineered 2021;12:7335-47. [PMID: 34612768 DOI: 10.1080/21655979.2021.1971030] [Reference Citation Analysis]